pv-001-dc
Vaccineexperimental
Clinical trial activity
3 trials · 3 clinical orgs · 0 marketing orgs
Phase 1
3
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Oct 31, 2019 (NCT03989895)
Timeline
2010s
- Jan 1, 2019
Earliest Phase 1 Sponsor(trial)
Indications
Studied for
Mechanism of action
- Tumor antigensImmunity, active
immunity, active - tumor antigens
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT03990493 | Phase 1 | Dec 31, 2019 | Advocate Healthcare, PrimeVax Immuno-Oncology Inc., United States Army |
| NCT03803397 | Phase 1 | Nov 30, 2019 | Advocate Healthcare, PrimeVax Immuno-Oncology Inc. |
| NCT03989895 | Phase 1 | Oct 31, 2019 | Advocate Healthcare, PrimeVax Immuno-Oncology Inc., United States Army |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (3)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Advocate Healthcare | Academic/Hospital | 3 | 0 | 1 | 2019 |
| PrimeVax Immuno-Oncology Inc. | For profit | 3 | 3 | 1 | 2019 |
| United States Army | Government | 2 | 0 | 1 | 2019 |
3 organizations
Page 1 / 1